Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis. [electronic resource]
Producer: 20051205Description: 386-92 p. digitalISSN:- 1352-0504
- Adenine -- analogs & derivatives
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Drug Resistance, Viral -- genetics
- Female
- Hepatic Encephalopathy
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- complications
- Humans
- Lamivudine -- therapeutic use
- Liver Cirrhosis -- drug therapy
- Male
- Middle Aged
- Mutation
- Organophosphonates -- therapeutic use
- Survival Analysis
- Taiwan
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.